Literature DB >> 11470390

Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study.

M D Howell1, J M Geraci, A A Knowlton.   

Abstract

Although CHF has been considered a risk factor for venous thromboembolism, this has not been directly studied. We hypothesized that congestive heart failure would increase the risk of venous thromboembolism in an outpatient population, and that this risk would increase as patients' ventricular function worsened. We conducted a case-control study to examine whether CHF due to left ventricular dysfunction was an independent risk factor for acute venous thromboembolism in outpatients, once established risk factors such as recent surgery and prior venous thromboembolism are taken into account. We reviewed 106 cases of DVT and 603 controls, admitted for diabetes mellitus or infection, matched for month of admission at a VA hospital. Assignment of a diagnosis of venous thromboembolism required a definitive test, as did classification as CHF. In a logistic regression model CHF was an independent predictor of venous thromboembolism. A second logistic regression model showed that the risk of venous thromboembolism increased as the ejection fraction (EF) decreased, with an EF < 20 associated with a venous thromboembolism OR of 38.3 (95% CI 9.6, 152.5). CHF is an independent risk factor for venous thromboembolism, and the risk increases markedly as the EF decreases. These results support the use of anticoagulation in selected patients with CHF.

Entities:  

Mesh:

Year:  2001        PMID: 11470390     DOI: 10.1016/s0895-4356(00)00373-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  27 in total

1.  Predictors of complications and readmission following spinal stereotactic radiosurgery.

Authors:  Daniel Lubelski; Joseph E Tanenbaum; Taylor E Purvis; Thomas T Bomberger; Courtney Rory Goodwin; Ilya Laufer; Daniel M Sciubba
Journal:  CNS Oncol       Date:  2017-07-18

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease.

Authors:  Victor Kim; Nishant Goel; Jinal Gangar; Huaqing Zhao; David E Ciccolella; Edwin K Silverman; James D Crapo; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2014

4.  Incidence of venous thromboembolism in care homes: a prospective cohort study.

Authors:  Patricia N Apenteng; Fd Richard Hobbs; Andrea Roalfe; Usman Muhammad; Carl Heneghan; David Fitzmaurice
Journal:  Br J Gen Pract       Date:  2017-01-16       Impact factor: 5.386

5.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

6.  Current state of medical thromboprophylaxis in Australia.

Authors:  Sophie E Noel; J Alasdair Millar
Journal:  Australas Med J       Date:  2014-02-28

7.  The risk of venous thromboembolism is markedly elevated in patients with diabetes.

Authors:  V Petrauskiene; M Falk; I Waernbaum; M Norberg; J W Eriksson
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

8.  Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Alexander G G Turpie; Peter Wildgoose; Roger D Yusen
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

9.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

10.  Outcome of patients with pulmonary embolism admitted to the intensive care unit.

Authors:  Hadeel Al Otair; Mohammed Chaudhry; Shaffi Shaikh; Ahmed Bahammam
Journal:  Ann Thorac Med       Date:  2009-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.